Duration of nonmethadone outpatient treatment: Results from a national survey

Substance Abuse

Volumn 27, Issue 3, 2006, Pages 47-53

  Friedmann, Peter D ^a,d   Alexander, Jeffrey A ^b   Yey, Yining ^b   Nahra, Tammie ^b   Soliman, Soheil ^b   Pollack, Harold A ^c  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

Outpatient substance abuse treatment centers; Substance related disorders; Treatment retention; Trends

Indexed keywords

ADDICTION; ARTICLE; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; MANAGED CARE; MENTAL HEALTH CENTER; OUTPATIENT CARE; PATIENT ATTITUDE; TREATMENT DURATION; UNITED STATES;

ADULT; ALCOHOLISM; AMBULATORY CARE; FEMALE; HEALTH SURVEYS; HUMANS; LENGTH OF STAY; MALE; METHADONE; NARCOTICS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DROPOUTS; PRISONERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 33751293325     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1300/J465v27n03_07     Document Type: Article

References (28)

1. Prendergast ML, Podus D, Chang E, Urada D. The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies. Drug Alcohol Depend. 2002; 67(1):53-72.
2. Gerstein DR, Harwood HJ, eds. Treatment of Drug Problems: A Study of the Evolution, Effectiveness and Financing of Public and Private Drug Treatment Systems. Report of the Committee for the Substance Abuse Coverage Study, Division of Health Care Services. Institute of Medicine. Washington, DC: National Academy Press; 1990.
3. Simpson DD. The relation of time spent in drug abuse treatment to posttreatment outcome. Am J Psychiatry. 1979; 136:1449-1453.
4. Grella CE, Hser YI, Joshi V, Anglin MD. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug Alc Depend. 1999; 57:151-166.
5. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003; 98(5):673-684.
6. Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend. 2001; 62(3):255-264.
7. Weisner C, Schmidt LA. Rethinking access to alcohol treatment. Recent Dev Alcohol. 2001; 15:107-136.
8. Larson MJ, Samet JH, McCarty D. Managed care of substance abuse disorders. Implications for generalist physicians. Med Clin North Am. 1997; 81:1053-1069.
9. Mechanic D. The state of behavioral health in managed care. Am J Manag Care 1999; 5 Spec No: SP17-SP21.
10. Wheeler JR, Nahra TA. Private and public ownership in outpatient substance abuse treatment: do we have a two-tiered system? Adm Policy Ment Health. 2000; 27(4):197-209.
11. Galanter M, Keller DS, Dermatis H, Egelko S. The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine. J Addict Dis. 2000; 19(3):13-34.
12. Scott WR. Organiztaions: Natural, Rational and Open Systems. Fourth edition. Englewood Cliffs, NJ: Prentice-Hall; 1998.
13. Pfeffer J, Salancik GR. The External Control of Organizations: A Resource Dependency Perspective. New York: Harper & Row; 1978.
14. Lemak CH, Alexander JA. Managed care and outpatient substance abuse treatment intensity. J Behav Health Serv Res. 2001; 28(1):12-29.
15. Sosin MR, D'Aunno T. The organization of substance abuse managed care. Recent Dev Alcohol. 2001; 15:27-49.
16. Durkin EM. An organizational analysis of psychosocial and medical services in drug abuse treatment programs. Soc Serv Rev. 2002; 76:406-429.
17. D'Aunno T, Folz-Murphy N, Lin X. Changes in methadone treatment practices: results from a panel study, 1988-1995. Am J Drug Alcohol Abuse. 1999; 25(4):681-699.
18. Adams TK, Heeringa SG. Outpatient Substance Abuse Treatment System Surveys (OSATSS). Technical Documentation for OSATSS-5, 1999-2000. Ann Arbor, MI: Survey Design and Analysis Unit, Survey Research Center, Institute for Social Research, University of Michigan; 2001.
19. Groves RM, Biemer PP, Lyberg LE, Massey JT, Nichols II WL, Waksberg J. Telephone Survey Methodology. New York: Wiley; 1988.
20. Batten HL, Prottas JM, Horgan CM, Ellis SE, Simon LJ, Larson MJ et al. Drug Services Research Survey. Final Report Phase II. Waltham, MA: Institute for Health Policy, Brandeis University; 1991.
21. Batten HL, Horgan CH, Prottas JM, Simon LJ, Larson MJ, Elliot EA et al. Drug Services Research Survey. Phase I Final Report: Non-Correctional Facilities. Waltham, MA: Institute for Health Policy, Brandeis University; 1993.
22. Substance Abuse and Mental Health Services Administration OoAS. Services Research Outcomes Study. DHHS Publication No. (SMA) 98-3177. Analytic Series: A-5. Rockville, MD, U.S. Department of Health and Human Services 1998.
23. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986; 73: 13-22.
24. Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res. 1999; 34(3):791-806.
25. Green CA, Polen MR, Dickinson DM, Lynch FL, Bennett MD. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abuse Treat. 2002; 23(4):285-295.
26. D'Aunno T, Pollack HA. Changes in methadone treatment practices: results from a national panel study, 1988-2000. JAMA. 2002; 288(7):850-856.
27. Piantadosi S, Byar DP, Green SB. The ecological fallacy. Am J Epidemiol. 1988; 127(5):893-904.
28. Moos RH, Finney JW. Substance abuse treatment programs and processes: linkages to patients' needs and outcomes. J Subst Abuse. 1995; 7:1-8.